Tag: ICH Q1B photostability

Ensuring Consistency Across Multiple UV Meters

In photostability testing, especially under ICH Q1B guidelines, reliable UV exposure is critical. Many pharmaceutical facilities operate multiple UV meters—each with varying response characteristics, sensor sensitivities, and calibration histories. This tutorial explains how to ensure measurement consistency across multiple UV meters used in regulated environments. Why UV Meter Consistency Is Critical in GMP Testing Using…

Equipment and Calibration

How to Verify Light Exposure Uniformity in Chambers for Photostability Testing

Verifying the uniformity of light exposure in photostability testing chambers is essential for generating valid, reproducible data. Regulatory authorities such as the USFDA and ICH Q1B guideline emphasize the need for consistent and homogenous illumination during forced degradation and stability trials. This tutorial outlines how to verify light distribution across the testing zone, the equipment…

Equipment and Calibration

How to Calibrate Lux Meters for ICH Q1B Photostability Testing

Photostability testing under ICH Q1B guidelines is a crucial requirement in pharmaceutical stability studies. It ensures that drug substances and products maintain their quality under exposure to light. A vital tool in this process is the **lux meter** — a device used to measure the intensity of visible light within stability chambers. But the accuracy…

Equipment and Calibration

TGA Photostability Requirements Explained Step-by-Step

Australia’s Therapeutic Goods Administration (TGA) enforces rigorous stability testing requirements, including photostability, for pharmaceutical product registration. While the TGA references ICH Q1B, it has some region-specific expectations, especially for documentation and packaging evaluations. This step-by-step guide will walk you through TGA-compliant photostability studies to avoid regulatory delays or deficiencies. 💡 Step 1: Understand the Basis…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Spectroscopic Tools in Stability Testing: FTIR and UV-Vis Applications

Spectroscopic Tools in Stability Testing: FTIR and UV-Vis Applications Applications of FTIR and UV-Vis Spectroscopy in Pharmaceutical Stability Studies Introduction Stability Studies in pharmaceutical development require robust analytical techniques capable of identifying chemical and physical changes in drug products over time. While chromatographic methods like HPLC and GC dominate impurity profiling, spectroscopic techniques such as…

Analytical Techniques in Stability Studies, Spectroscopic Methods for Stability Testing (FTIR, UV-Vis)

ICH Stability Guidelines: In-Depth Review of Q1A–Q1E, Q8, Q9

ICH Stability Guidelines: In-Depth Review of Q1A–Q1E, Q8, Q9 Complete Guide to ICH Stability Guidelines: Q1A–Q1E, Q8, Q9 and Beyond Introduction The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has significantly shaped the global regulatory landscape, particularly in the realm of stability testing. The ICH Q1A–Q1E series outlines the…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines

Packaging Materials in Controlling Photostability and Humidity in Pharmaceuticals

Packaging Materials in Controlling Photostability and Humidity in Pharmaceuticals How Packaging Materials Impact Photostability and Humidity Control in Pharmaceuticals Introduction The protection of pharmaceuticals from environmental factors is a cornerstone of packaging design. Among the most critical threats to drug stability are exposure to light and moisture—both capable of initiating degradation pathways that compromise safety,…

Impact of Packaging Materials on Photostability and Humidity Control, Pharmaceutical Packaging Stability

ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained

ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained Introduction Stability Studies are a critical part of the pharmaceutical development lifecycle. For active pharmaceutical ingredients (APIs), ensuring the chemical, physical, and microbiological integrity of the drug substance over time is essential to patient safety and product…

ICH Guidelines for API Stability (Q1A–Q1E, Q3C), Stability Studies for APIs